Table 2 Sedative, opioid, and psychotropic medication use.
Medication daily dose in Mg | Total sample (n = 474) | SICU (n = 121) | MICU (n = 353) | P value |
---|---|---|---|---|
Median [IQR] | ||||
Lorazepam equivalentsa | 0.4 [0.0, 3.70] | 1.1 [0.0, 10.50] | 0.3 [0.0, 2.00] | 0.007 |
Propofol | 0.0 [0.0, 271.60] | 0.0 [0.0, 127.5] | 0.0 [0.0, 272.4] | 0.52 |
Dexmedetomidine | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.38 |
Haloperidol | 0.0 [0.0, 0.6] | 0.0 [0.0, 1.3] | 0.0 [0.0, 0.4] | 0.06 |
Quetiapinea | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | < 0.001 |
Risperdal | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.09 |
Olanzapine | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.50 |
Clonidine | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.0 [0.0, 0.0] | 0.06 |
Morphine equivalentsa | 32.6 [3.4, 100.3] | 56.7 [5.4, 149.0] | 29.2 [2.5, 92] | 0.002 |
Any medication use in first 7 days | ||||
No. (%) with data | ||||
Lorazepam equivalents | 309 (65) | 83 (69) | 226 (64) | 0.38 |
Propofol | 186 (39) | 43 (36) | 143 (41) | 0.39 |
Dexmedetomidine | 41 (9) | 13 (11) | 28 (8) | 0.35 |
Haloperidol | 170 (36) | 48 (40) | 122 (35) | 0.32 |
Quetiapinea | 37 (8) | 21 (17) | 16 (5) | < 0.001 |
Risperdal | 1 (.2) | 1 (1) | 0 (0) | 0.26 |
Olanzapine | 7 (2) | 1 (1) | 6 (2) | 0.68 |
Clonidine | 24 (5) | 10 (8) | 14 (4) | 0.09 |
Morphine equivalents | 414 (87) | 112 (92) | 302 (86) | 0.06 |